{
    "organizations": [],
    "uuid": "6dbacaa61ee5e901d1aae40badeb5106a3d8af64",
    "author": "",
    "url": "https://www.reuters.com/article/brief-aquinox-and-astellas-announce-excl/brief-aquinox-and-astellas-announce-exclusive-licensing-agreement-for-rosiptor-in-asia-pacific-region-including-japan-idUSFWN1SG1QA",
    "ord_in_thread": 0,
    "title": "BRIEF-Aquinox And Astellas Announce Exclusive Licensing Agreement For Rosiptor In Asia-Pacific Region Including Japan",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 9 (Reuters) - Astellas Pharma Inc:\n* AQUINOX AND ASTELLAS ANNOUNCE EXCLUSIVE LICENSING AGREEMENT FOR ROSIPTOR IN ASIA-PACIFIC REGION INCLUDING JAPAN\n* AQUINOX PHARMACEUTICALS SAYS AQUINOX TO RECEIVE $25 MILLION IN UPFRONT PAYMENT, POTENTIALLY OVER $100 MILLION IN ADDITIONAL MILESTONE PAYMENTS AND ROYALTIES\n* AQUINOX- ASTELLAS WILL HAVE EXCLUSIVE RIGHT TO RESEARCH, DEVELOP, COMMERCIALIZE ROSIPTOR FOR ALL HUMAN DISEASES AND CONDITIONS IN JAPAN, OTHER APAC COUNTRIES Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-10T04:12:00.000+03:00",
    "crawled": "2018-05-10T04:28:48.027+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "astellas",
        "pharma",
        "inc",
        "aquinox",
        "astellas",
        "announce",
        "exclusive",
        "licensing",
        "agreement",
        "rosiptor",
        "region",
        "including",
        "japan",
        "aquinox",
        "pharmaceutical",
        "say",
        "aquinox",
        "receive",
        "million",
        "upfront",
        "payment",
        "potentially",
        "million",
        "additional",
        "milestone",
        "payment",
        "royalty",
        "astellas",
        "exclusive",
        "right",
        "research",
        "develop",
        "commercialize",
        "rosiptor",
        "human",
        "disease",
        "condition",
        "japan",
        "apac",
        "country",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}